title: Imatinib-induced Extensive Hyperpigmentation in a Case of Chronic Myeloid Leukemia.
abstract: Imatinib, a tyrosine kinase inhibitor, is well known to cause hypopigmentation because of its inhibitory effect on melanocytes. Herewith we report a case of chronic myeloid leukemia who developed extensive hyperpigmentation following imatinib therapy.
authors.affiliation: Department of Dermatology, Amrita Institute of Medical Sciences, Ponekkara, Kochi, Kerala, India.
authors.forename: Pradeep
authors.initials: P
authors.lastname: Balasubramanian
authors.affiliation: Department of Dermatology, Amrita Institute of Medical Sciences, Ponekkara, Kochi, Kerala, India.
authors.forename: Soumya
authors.initials: S
authors.lastname: Jagadeesan
authors.affiliation: Department of Dermatology, Amrita Institute of Medical Sciences, Ponekkara, Kochi, Kerala, India.
authors.forename: Jacob
authors.initials: J
authors.lastname: Thomas
keywords: Hyperpigmentation; Imatinib; leukemia